Cargando…
Novel drugs and their targets in the potential treatment of diabetic retinopathy
Diabetic retinopathy (DR) is the most common complication of diabetes. It causes vision loss, and the incidence is increasing with the growth of the diabetes epidemic worldwide. Over the past few decades a number of clinical trials have confirmed that careful control of glycemia and blood pressure c...
Autores principales: | Nawaz, Mohd Imtiaz, Abouammoh, Marwan, Khan, Haseeb A., Alhomida, Abdullah S., Alfaran, Mubarak F., Ola, Mohammad Shamsul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659065/ https://www.ncbi.nlm.nih.gov/pubmed/23619778 http://dx.doi.org/10.12659/MSM.883895 |
Ejemplares similares
-
Neurodegeneration and Neuroprotection in Diabetic Retinopathy
por: Ola, Mohammad Shamsul, et al.
Publicado: (2013) -
Neurodegeneration in Diabetic Retina and Its Potential Drug Targets
por: Ola, Mohammad Shamsul, et al.
Publicado: (2014) -
High-Mobility Group Box-1 and Endothelial Cell Angiogenic Markers in the Vitreous from Patients with Proliferative Diabetic Retinopathy
por: Abu El-Asrar, Ahmed M., et al.
Publicado: (2012) -
High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy
por: El-Asrar, Ahmed M. Abu, et al.
Publicado: (2011) -
Modulation of the Structure and Stability of Novel Camel Lens Alpha-Crystallin by pH and Thermal Stress
por: Malik, Ajamaluddin, et al.
Publicado: (2022)